These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9266153)

  • 21. Cell cycle regulation of neuronal apoptosis in development and disease.
    Becker EB; Bonni A
    Prog Neurobiol; 2004 Jan; 72(1):1-25. PubMed ID: 15019174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chondroitin sulfate proteoglycans are a common component of neuronal inclusions and astrocytic reaction in neurodegenerative diseases.
    DeWitt DA; Richey PL; Praprotnik D; Silver J; Perry G
    Brain Res; 1994 Sep; 656(1):205-9. PubMed ID: 7804839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degenerative diseases.
    Curr Opin Neurol; 1997 Aug; 10(4):B87-101. PubMed ID: 9266163
    [No Abstract]   [Full Text] [Related]  

  • 24. Etiology of the neurodegenerative disorders: a critical analysis.
    Rose CD; Henneberry RC
    Neurobiol Aging; 1994; 15(2):233-4. PubMed ID: 7838297
    [No Abstract]   [Full Text] [Related]  

  • 25. Trinucleotide-repeat expansions and neurodegenerative diseases.
    Hannan AJ
    Trends Neurosci; 1995 Oct; 18(10):440. PubMed ID: 8545907
    [No Abstract]   [Full Text] [Related]  

  • 26. Polyneuropathy due to ethylene oxide, propylene oxide, and butylene oxide.
    Ohnishi A; Murai Y
    Environ Res; 1993 Feb; 60(2):242-7. PubMed ID: 8472653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis in neurological disease.
    Savitz SI; Rosenbaum DM
    Neurosurgery; 1998 Mar; 42(3):555-72; discussion 573-4. PubMed ID: 9526991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Molecular and Cellular Basis of Human Neurodegenerative Disease. Keystone symposium. Breckenridge, Colorado, April 3-9, 1995. Abstracts.
    J Cell Biochem Suppl; 1995; 21B():83-113. PubMed ID: 7769828
    [No Abstract]   [Full Text] [Related]  

  • 29. Apoptosis in development and disease of the nervous system: 1. Naturally occurring cell death in the developing nervous system.
    Narayanan V
    Pediatr Neurol; 1997 Jan; 16(1):9-13. PubMed ID: 9044394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms of microglial activation. A. Implications for regeneration and neurodegenerative diseases.
    Gebicke-Haerter PJ; Van Calker D; Nörenberg W; Illes P
    Neurochem Int; 1996 Jul; 29(1):1-12. PubMed ID: 8808784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excitotoxicity and neurodegenerative diseases.
    Ikonomidou C; Turski L
    Curr Opin Neurol; 1995 Dec; 8(6):487-97. PubMed ID: 8845937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptosis II: Apoptosis in the pathogenesis and treatment of diseases.
    Moldoveanu E; Oros A; Hălălău FL; Popescu LM
    Rom J Morphol Embryol; 1996; 42(1-2):41-51. PubMed ID: 9038386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Degeneration of axotomized retinal ganglion cells as a model for neuronal apoptosis in the central nervous system - molecular death and survival pathways.
    Weishaupt JH; Bähr M
    Restor Neurol Neurosci; 2001; 19(1-2):19-27. PubMed ID: 12082226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axon pathology in neurological disease: a neglected therapeutic target.
    Coleman MP; Perry VH
    Trends Neurosci; 2002 Oct; 25(10):532-7. PubMed ID: 12220882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptosis and neurologic disease.
    Honig LS; Rosenberg RN
    Am J Med; 2000 Mar; 108(4):317-30. PubMed ID: 11014725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of tau-2 positive microglia-like cells in the subcortical nuclei of human neurodegenerative disorders.
    Odawara T; Iseki E; Kosaka K; Akiyama H; Ikeda K; Yamamoto T
    Neurosci Lett; 1995 Jun; 192(3):145-8. PubMed ID: 7566636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathology of ventral spinal outflow in the neurodegenerative diseases--size-dependent axonal loss].
    Sobue G
    No To Shinkei; 1988 Jan; 40(1):33-45. PubMed ID: 3282528
    [No Abstract]   [Full Text] [Related]  

  • 38. Dysfunction and death of neurons in human degenerative neurological diseases and in animal models.
    Price DL; Cork LC; Struble RG; Kitt CA; Walker LC; Powers RE; Whitehouse PJ; Griffin JW
    Ciba Found Symp; 1987; 126():30-48. PubMed ID: 3556088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases.
    Doré S; Kar S; Quirion R
    Trends Neurosci; 1997 Aug; 20(8):326-31. PubMed ID: 9246719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Glial cytoskeletal abnormalities in neurodegenerative diseases].
    Ikeda K
    No To Shinkei; 1996 Oct; 48(10):885-94. PubMed ID: 8921527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.